(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MARENGO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MARENGO

ST13

US500000097111783

Class

42

Filing

97111783

Registration

8078739

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

12/23/2025

Trademark type

Combined

Nice classes

42

Filing date

11/05/2021

Registration date

12/23/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/23/2025

Last transaction

12/23/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/01/2022

First use in commerce

08/01/2022

Drawing code

3

Owner type

03

Owner location

Cambridge, MA, US

Examiner

SHOOR, AMIT KUMAR

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word MARENGO in stylized font with the stylized image of a horse's head to the left.

Holders and representatives

Holders

MARENGO THERAPEUTICS, INC.

Representatives

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific researchconducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immunity; research and development in pharmacology for the purpose of triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; medical research services in the field of cancer; medical and scientific research in the field of cancer treatment; medical and scientific research for immune system activation and protection; research and development for the purpose of anti-cancer immune activation therapeutics; medical and scientific research in the fields of immunology and oncology for treating cancerinfectious diseaseauto-immune diseaseother diseases in connection with immune system dysfunction; research and development of vaccines and medicines

Publications

History of USPTO decisions and trademark events.

38 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/23/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

12/23/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/03/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/03/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/14/2025

IUAF

USE AMENDMENT FILED

11/12/2025

EISU

TEAS STATEMENT OF USE RECEIVED

11/12/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/09/2025

EX5G

SOU EXTENSION 5 GRANTED

04/08/2025

EXT5

SOU EXTENSION 5 FILED

04/07/2025

EEXT

SOU TEAS EXTENSION RECEIVED

04/07/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/23/2025

EX4G

SOU EXTENSION 4 GRANTED

01/22/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/15/2025

EXT4

SOU EXTENSION 4 FILED

11/14/2024

EEXT

SOU TEAS EXTENSION RECEIVED

11/14/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/04/2024

EX3G

SOU EXTENSION 3 GRANTED

05/03/2024

EXT3

SOU EXTENSION 3 FILED

05/03/2024

EEXT

SOU TEAS EXTENSION RECEIVED

05/03/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/19/2023

EX2G

SOU EXTENSION 2 GRANTED

10/17/2023

EXT2

SOU EXTENSION 2 FILED

10/17/2023

EEXT

SOU TEAS EXTENSION RECEIVED

10/17/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/17/2023

EX1G

SOU EXTENSION 1 GRANTED

05/15/2023

EXT1

SOU EXTENSION 1 FILED

05/15/2023

EEXT

SOU TEAS EXTENSION RECEIVED

05/15/2023

DOCK

ASSIGNED TO EXAMINER

02/21/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/15/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/20/2022

PUBO

PUBLISHED FOR OPPOSITION

09/20/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/31/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/16/2022

DOCK

ASSIGNED TO EXAMINER

08/16/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/17/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/16/2021

NWAP

NEW APPLICATION ENTERED

11/09/2021

Continuous trademark protection

Get notified about every new filing that threatens MARENGO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.